Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Rhea-AI Summary

Applied DNA Sciences, Inc. (NASDAQ:APDN) has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The company's president and CEO, Dr. James A. Hayward, will engage in a fireside chat on Wednesday, October 16, 2024, at 12:50 p.m. EDT. This virtual event, hosted by Maxim Group , runs from October 15th to 17th.

The interview will be conducted by Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research. Registered conference attendees will have access to view Applied DNA's fireside chat. Applied DNA, known for its leadership in PCR-based DNA technologies, will use this platform to share insights with the healthcare investment community.

STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit from October 15^th to 17^th.

Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research, will interview Dr. Hayward.Applied DNA's fireside chat will be available for viewing by registered conference attendees on Wednesday, October 16, 2024.

Details for the fireside chat are as follows:
Date: Wednesday, October 16, 2024
Time: 12:50 p.m. EDT
Presenter: James A. Hayward, president and chief executive officer of Applied DNA
Registration: link

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.

Contacts:

Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
X: @APDN

SOURCE: Applied DNA Sciences

View the original press release on accesswire.com

FAQ

When is Applied DNA (APDN) participating in the 2024 Maxim Healthcare Virtual Summit?

Applied DNA (APDN) is participating in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16, 2024. The company's fireside chat is scheduled for 12:50 p.m. EDT on that day.

Who will represent Applied DNA (APDN) at the 2024 Maxim Healthcare Virtual Summit?

Dr. James A. Hayward, the president and chief executive officer of Applied DNA Sciences, will represent the company at the 2024 Maxim Healthcare Virtual Summit.

What is the format of Applied DNA's (APDN) presentation at the 2024 Maxim Healthcare Virtual Summit?

Applied DNA's presentation will be in the form of a fireside chat, where Dr. James A. Hayward will be interviewed by Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research.

How can investors view Applied DNA's (APDN) fireside chat at the 2024 Maxim Healthcare Virtual Summit?

Registered conference attendees will be able to view Applied DNA's fireside chat on Wednesday, October 16, 2024. Registration is required to access the virtual summit content.